Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years: Phase II randomized controlled trial in Singapore

por Sin Leo, Yee, Wilder-Smith, Annelies, Archuleta, Sophia, Shek, Lynette P., Chong, Chia Yin, Nam Leong, Hoe, Yong Low, Chian, Oh, May-Lin Helen, Bouckenooghe, Alain, Wartel, T. Anh, Crevat, Denis
Publicado 2012